Chemesis International Inc. (the “Company”) (CSE: CSI) (OTC: CADMF) (FRA: CWAA) The Company announces that the Department of Health of Puerto Rico (“Department of Heath”) is conducting a review of certain filings made by the Company’s subsidiaries, Natural Ventures PR LLC (“NVPR”) and GSRX Industries Inc. (“GSRX”) with the Department of Health. This review is in addition to the ongoing administrative review by the Department of Health previously announced by the Company (see news releases dated August 7, 2020 and January 17, 2020).

The Company’s Puerto Rico legal counsel have been in contact with the Department of Health and will have an opportunity to discuss and address this matter through an administrative process expected to commence within the next few days. The Company, through its local legal counsel, has been informed that the Licenses will remain intact during such process.


At present, the Company’s operations under the Licenses continue in the ordinary course.

On Behalf of The Board of Directors
Josh Rosenberg
President
Investor Relations:
ir@chemesis.com
1 (604) 398-3378

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the ability of the Company to continue to operate under the Licenses, and the ability of the Company to engage in any administrative process with the Department of Health. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements including, among other things, the risks that the Company will not be able to maintain or continue licensed activities under the Licences as currently being conducted, or at all, and that the Company’s products and plans will vary significantly as a result, and that the Company will not be permitted to engage with the Department of Health through an administrative or other process to address the concerns raised. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release

Source

A Toronto-based company is set to become the first cannabis operation to transition to the real estate investment trust (REIT) model.

At the start of October, Subversive Real Estate Acquisition REIT LP (NEO:SVX.U,OTC Pink:SBVRF) announced to the market a qualifying transaction that will allow it to finish the process of becoming a special purpose acquisition company (SPAC).

Keep reading... Show less

CEO recognized for economic development across the minority community in the Big Bend Florida region

Trulieve Cannabis Corp. (CSE: TRUL & OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that Chief Executive Officer Kim Rivers was awarded the 2020 Women Business Enterprise of the Year Award. The award celebrates the work of businesses and leaders in Florida’s Big Bend area who are driving innovation, expanding a business, and fostering job creation in the majority-minority community.

Keep reading... Show less

The 64 th storefront in Florida offers the largest inventory of medical cannabis products in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 66th nationwide. The new dispensary will be the first location in Punta Gorda and third in Charlotte County to bring the Company’s wide-ranging catalog of medical cannabis products directly to patients.

Keep reading... Show less
  • Existing At-The-Market (ATM) program now complete
  • New Preliminary Base Shelf Prospectus Has Been Filed
  • Current Cash Position is Approximately $272 million

NYSE | TSX: ACB

Aurora Cannabis Inc. (the ” Company ” or ” Aurora “) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced it has completed the previously filed At-The-Market (“ATM”) program. Because of this, the Company has filed a new preliminary short form base shelf prospectus (the “Shelf Prospectus”) with securities regulators in each of the provinces of Canada except Quebec and a corresponding shelf registration statement on Form F–10 (the “Registration Statement”) with the United States Securities and Exchange Commission (the “SEC”).

Keep reading... Show less

 Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) is pleased to announce that its majority owned subsidiary NeonMind Biosciences (“NeonMind”) has completed an initial production run of all four of its Ayurvedic, functional mushroom coffees.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/66901_b3bb261db486a838_001.jpg

Keep reading... Show less